Plasma S-adenosylhomocysteine is associated with the risk of cardiovascular events in patients undergoing coronary angiography: A cohort study

American Journal of Clinical Nutrition

Volumn 98, Issue 5, 2013, Pages 1162-1169

  Xiao, Yunjun ^a,b   Zhang, Yuan ^c   Wang, Min ^a   Li, Xinrui ^a   Su, Dongfang ^a   Qiu, Jian ^c   Li, Dan ^a   Yang, Yan ^a   Xia, Min ^a   Ling, Wenhua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CREATININE; FOLIC ACID; HOMOCYSTEINE; LIPID; METHIONINE; PLASMA S ADENOSYLHOMOCYSTEINE; S ADENOSYLHOMOCYSTEINE; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE STUDY; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROSPRAY; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; GROUPS BY AGE; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; LIMIT OF QUANTITATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SMOKING; TANDEM MASS SPECTROMETRY; TELECONSULTATION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; S-ADENOSYLHOMOCYSTEINE; STROKE; YOUNG ADULT;

EID: 84886303845     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.058727     Document Type: Article

References (32)

1. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-55.
2. Zhou J, Moller J, Danielsen CC, Bentzon J, Ravn HB, Austin RC, Falk E. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2001;21:1470-6.
3. Loscalzo J. Homocysteine trials-clear outcomes for complex reasons. N Engl J Med 2006;354:1629-32.
4. Spence JD. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol 2007;6:830-8.
5. Cantoni GL. The role of S-Adenosylhomocysteine in the biological utilization of S-Adenosylmethionine. Prog Clin Biol Res 1985;198:47-65.
6. HoffmanDR, MarionDW,Cornatzer WE,Duerre JA. S-Adenosylmethionine and S-Adenosylhomocysteine metabolism in isolated rat liver. Effects of L-methionine, L-homocysteine, and adenosine. J Biol Chem 1980;255: 10822-7.
7. Hoffman DR, Cornatzer WE, Duerre JA. Relationship between tissue levels of S-Adenosylmethionine, S-Adenylhomocysteine, and transmethylation reactions. Can J Biochem 1979;57:56-65.
8. Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME, Blom HJ, Jakobs C, Tavares de Almeida I. Increased homocysteine and S- Adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003;49:1292-6.
9. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-Adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000;275:29318-23.
10. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma S-Adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 2001;74:723-9.
11. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975;51:5-40.
12. Zhang B, Wang P, Chen CG, He QQ, Zhuo SY, Chen YM, Su YX. Validation of an FFQ to estimate the intake of fatty acids using erythrocyte membrane fatty acids and multiple 3d dietary records. Public Health Nutr 2010;13:1546-52.
13. Yang Y, Wang G, Pan X. China food composition. Beijing, China: Peking University Medical Press, 2002.
14. Gellekink H, van Oppenraaij-Emmerzaal D, van Rooij A, Struys EA, den Heijer M, Blom HJ. Stable-isotope dilution liquid chromatographyelectrospray injection tandem mass spectrometry method for fast, selective measurement of S-Adenosylmethionine and S-Adenosylhomocysteine in plasma. Clin Chem 2005;51:1487-92.
15. Ubbink JB, Hayward Vermaak WJ, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441-6.
16. Struys EA, Jansen EE, de Meer K, Jakobs C. Determination of Sadenosylmethionine and S-Adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry. Clin Chem 2000;46:1650-6.
17. Grossowicz N, Waxman S, Schreiber C. Cryoprotected Lactobacillus casei: an approach to standardization of microbiological assay of folic acid in serum. Clin Chem 1981;27:745-7.
18. Cox D. Regression models and life tables (with discussion). J R Stat Soc, B 1972;34:187-220.
19. Caudill MA,Wang JC, Melnyk S, Pogribny IP, Jernigan S, Collins MD, Santos-Guzman J, Swendseid ME, Cogger EA, James SJ. Intracellular S-Adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J Nutr 2001;131:2811-8.
20. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-Adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 2002;132:2361S-6S.
21. Böger RH, Bode-Boger SM, Sydow K, Heistad DD, Lentz SR. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst( e)inemia or hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000;20:1557-64.
22. Chang PY, Lu SC, Lee CM, Chen YJ, Dugan TA, Huang WH, Chang SF, Liao WS, Chen CH, Lee YT. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res 2008;102:933-41.
23. Wang H, Yoshizumi M, Lai K, Tsai JC, Perrella MA, Haber E, Lee ME. Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem 1997;272:25380-5.
24. Valli A, Carrero JJ, Qureshi AR, Garibotto G, Barany P, Axelsson J, Lindholm B, Stenvinkel P, Anderstam B, Suliman ME. Elevated serum levels of S-Adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients. Clin Chim Acta 2008;395:106-10.
25. Lin PY, Yang TH, Lin HG, Hu ML. Synergistic effects of Sadenosylhomocysteine and homocysteine on DNA damage in a murine microglial cell line. Clin Chim Acta 2007;379:139-44.
26. Wagner C, Koury MJ. S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine? Am J Clin Nutr 2007;86:1581-5.
27. Wagner C, Stone WJ, Koury MJ, Dupont WD, Kerins DM. SAdenosylhomocysteine is a more sensitive indicator of renal insufficiency than homocysteine. Nutr Res 2004;24:487-94.
28. Herrmann W, Schorr H, Obeid R, Makowski J, Fowler B, Kuhlmann MK. Disturbed homocysteine and methionine cycle intermediates S-Adenosylhomocysteine and S-Adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes. Clin Chem 2005;51:891-7.
29. Loehrer FM, Angst CP, Brunner FP, Haefeli WE, Fowler B. Evidence for disturbed S-Adenosylmethionine: S-Adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions? Nephrol Dial Transplant 1998;13:656-61.
30. El-Khairy L, Ueland PM, Refsum H, Graham IM, Vollset SE. Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project. Circulation 2001;103:2544-9.
31. El-Khairy L, Vollset SE, Refsum H, Ueland PM. Plasma total cysteine, mortality, and cardiovascular disease hospitalizations: the Hordaland Homocysteine Study. Clin Chem 2003;49:895-900.
32. Becker A, Smulders YM, Teerlink T, Struys EA, de Meer K, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, et al. S-Adenosylhomocysteine and the ratio of S-Adenosylmethionine to S-Adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations. Eur J Clin Invest 2003;33:17-25.